Apoptosis
Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
- Caspase(102)
- 14.3.3 Proteins(2)
- Apoptosis Inducers(45)
- Bax(7)
- Bcl-2 Family(122)
- Bcl-xL(8)
- c-RET(9)
- IAP(27)
- KEAP1-Nrf2(67)
- MDM2(15)
- p53(128)
- PC-PLC(5)
- PKD(8)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(151)
- Other Apoptosis(900)
- Apoptosis Detection
- Caspase Substrate
- APC(6)
- PD-1/PD-L1 interaction(91)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Pyroptosis(32)
Apoptosis 相关产品(2721)
- GC66378SerplulimabCAS: 2231029-82-4纯度: >99.00%
Serplulimab (HLX 10) 是人源化单克隆抗 PD-1 抗体。Serplulimab 可用于小细胞肺癌的研究。
- GC66382LucatumumabCAS: 903512-50-5纯度: >95.00%
Lucatumumab (HCD122) 是一种全人抗 CD40 拮抗剂单克隆抗体,可阻断 CD40/ CD40L 介导的信号通路。Lucatumumab 可有效介导抗体依赖性细胞介导的细胞毒性 (ADCC) 和肿瘤细胞清除,可用于顽固性淋巴瘤、慢性淋巴细胞白血病 (CLL) 和多发性骨髓瘤研究。
- GC66403Z-DEVD-AMC纯度: >99.00%
Z-DEVD-AMC 是一种选择性 caspase-3 底物,可通过荧光光谱法测量。 AMC 可用作基于 AMC 的酶底物 (包括基于 AMC 的半胱天冬酶底物) 的荧光参考标准。
- GC66479GSK2593074ACAS: 1337531-06-2纯度: >98.00%
GSK2593074A (GSK'074) 是一种程序性坏死 (necroptosis) 抑制剂, 抑制 RIP1 和 RIP3。
- GC66824D-α-Tocopherol SuccinateCAS: 4345-03-3
D-α-Tocopherol Succinate (Vitamin E succinate) 是一种抗氧化生育酚,是维生素 E 的一种盐形式。D-α-Tocopherol Succinat 抑制 Cisplatin 引起的毒性。D-α-Tocopherol Succinate 可用于癌症的研究。
- GC67272N6-BenzyladenosineCAS: 4294-16-0纯度: >98.00%
DNPH1i (N6-benzyladenosine,BAPR) is a competitive inhibitor of adenosine deaminase(ADA) from L-1210 cells in axenic culture as well as a potent antiproliferative agent in vitro and in vivo.
- GC67618α-Tocopherol phosphate disodiumCAS: 60934-46-5
α-Tocopherol phosphate disodium是一种水溶性的α-生育酚。α-Tocopherol phosphate disodium可通过清除活性氧抑制和调节基因表达发挥功能。
- GC67694PD-1/PD-L1-IN-9 hydrochloride
PD-1/PD-L1-IN-9 盐酸盐是一种有效和具有口服活性的 PD-1/PD-L1 相互作用抑制剂,IC50 值为 3.8 nM。PD-1/PD-L1-IN-9 盐酸盐可以增强免疫细胞对肿瘤细胞的杀伤活性。PD-1/PD-L1-IN-9 盐酸盐在 CT26 小鼠模型中表现出显着的体内抗肿瘤活性。
- GC67765p53 Activator 5CAS: 2636840-37-2
p53 Activator 5 (compound 134A) 是一种有效的 p53 激活剂,SC150 值 <0.05 mM。p53 Activator 5 可以结合突变体 p53 并恢复 p53 突变体结合 DNA 的能力。p53 Activator 5 具有抗肿瘤活性。
- GC67936LupiwighteoneCAS: 104691-86-3纯度: >98.00%
Lupiwighteone 是一种广泛存在于野生植物中的异黄酮,具有抗氧化、抗菌和抗癌作用。Lupiwighteone 通过抑制 PI3K/Akt/mTOR 通路,诱导人乳腺癌细胞 caspase 依赖性和非依赖性凋亡 (Apoptosis)。
- GC67966MethylstatCAS: 1310877-95-2
Methylstat 是一种有效的组蛋白去甲基化酶 (histone demethylases) 抑制剂。Methylstat 具有抗增殖活性,低细胞毒性。Methylstat 诱导细胞凋亡 (Apoptosis) 和细胞周期停滞在 G0/G1 期。Methylstat 增加 p53 和 p21 蛋白水平的表达。Methylstat 抑制由各种细胞因子诱导的血管生成。Methylstat 可用作化学探针以解决其在血管生成中的作用。
- GC67969RIP1/RIP3/MLKL activator 1CAS: 2682850-41-3
RIP1/RIP3/MLKL activator 1 (Compound 6i) 是一种有效的抗胶质瘤 (anti-glioma) 药物。RIP1/RIP3/MLKL activator 1 通过激活 RIP1/RIP3/MLKL 通路诱导细胞坏死 (Necroptosis)。 RIP1/RIP3/MLKL activator 1 可透过血脑屏障。
- GC680432-tert-Butyl-1,4-benzoquinoneCAS: 3602-55-9纯度: >97.00%
2-tert-Butyl-1,4-benzoquinone 是 butylated hydroxyanisole 的亲电代谢产物,是 2-tert-butylhydroquinone 的氧化产物。
- GC68051Citric acid-d4CAS: 147664-83-3
Citric acid-d4 是 Citric acid 的氘代物。Citric acid 是柑橘类水果中发现的弱有机三羧酸。柠檬酸是天然防腐剂和食品添加剂。
- GC68213MitoBloCK-6CAS: 303215-67-0
MitoBloCK-6 是一种有效的 Erv1/ALR 抑制剂,IC50 分别为 900 nM 和 700 nM。MitoBloCK-6 还抑制 Erv2 (IC50=1.4 μM)。MitoBloCK-6 可通过细胞色素 c 的释放诱导 hESCs 细胞凋亡。
- GC682314-Methylsalicylic acidCAS: 50-85-1纯度: >99.00%
4-Methylsalicylic acid 是一种水杨酸。其衍生物是一种选择性的组织-非特异性碱性磷酸酶 (TNAP) 和肠道碱性磷酸酶 (IAP) 抑制剂。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC66378 | Serplulimab | 2231029-82-4 | >99.00% | |
Serplulimab (HLX 10) 是人源化单克隆抗 PD-1 抗体。Serplulimab 可用于小细胞肺癌的研究。 | ||||
| GC66382 | Lucatumumab | 903512-50-5 | >95.00% | |
Lucatumumab (HCD122) 是一种全人抗 CD40 拮抗剂单克隆抗体,可阻断 CD40/ CD40L 介导的信号通路。Lucatumumab 可有效介导抗体依赖性细胞介导的细胞毒性 (ADCC) 和肿瘤细胞清除,可用于顽固性淋巴瘤、慢性淋巴细胞白血病 (CLL) 和多发性骨髓瘤研究。 | ||||
| GC66394 | Penpulimab | 2350298-92-7 | - | |
Penpulimab 是一种 IgG1 抗 PD-1 单克隆抗体,具有抗肿瘤活性。 | ||||
| GC66403 | Z-DEVD-AMC | - | >99.00% | |
Z-DEVD-AMC 是一种选择性 caspase-3 底物,可通过荧光光谱法测量。 AMC 可用作基于 AMC 的酶底物 (包括基于 AMC 的半胱天冬酶底物) 的荧光参考标准。 | ||||
| GC66460 | UCB-5307 | 1515887-44-1 | >97.00% | |
UCB-5307 是一种 TNF 抑制剂,对人 TNFα 的 KD 为 9 nM。UCB-5307 可以穿透预制的 hTNF/hTNFR1 复合物。 | ||||
| GC66462 | MGH-CP1 | 896657-58-2 | >99.00% | |
MGH-CP1 is a potent and selective inhibitor of transcriptional enhanced associate domain (TEAD) palmitoylation. MGH-CP1 exhibits dose-dependent and potent inhibition of TEAD2/4 auto-palmitoylation in vitro with IC50 of 710 nM and 672 nM, respectively. | ||||
| GC66479 | GSK2593074A | 1337531-06-2 | >98.00% | |
GSK2593074A (GSK'074) 是一种程序性坏死 (necroptosis) 抑制剂, 抑制 RIP1 和 RIP3。 | ||||
| GC66824 | D-α-Tocopherol Succinate | 4345-03-3 | - | |
D-α-Tocopherol Succinate (Vitamin E succinate) 是一种抗氧化生育酚,是维生素 E 的一种盐形式。D-α-Tocopherol Succinat 抑制 Cisplatin 引起的毒性。D-α-Tocopherol Succinate 可用于癌症的研究。 | ||||
| GC67272 | N6-Benzyladenosine | 4294-16-0 | >98.00% | |
DNPH1i (N6-benzyladenosine,BAPR) is a competitive inhibitor of adenosine deaminase(ADA) from L-1210 cells in axenic culture as well as a potent antiproliferative agent in vitro and in vivo. | ||||
| GC67618 | α-Tocopherol phosphate disodium | 60934-46-5 | - | |
α-Tocopherol phosphate disodium是一种水溶性的α-生育酚。α-Tocopherol phosphate disodium可通过清除活性氧抑制和调节基因表达发挥功能。 | ||||
| GC67680 | BIO8898 | - | - | |
BIO8898 是一种有效的 CD40-CD154 抑制剂。BIO8898 抑制可溶性 CD40L 与 CD40-Ig 的结合,IC50 值为 25 µM。BIO8898 抑制 CD40L 诱导的细胞凋亡(Apoptosis)。 | ||||
| GC67694 | PD-1/PD-L1-IN-9 hydrochloride | - | - | |
PD-1/PD-L1-IN-9 盐酸盐是一种有效和具有口服活性的 PD-1/PD-L1 相互作用抑制剂,IC50 值为 3.8 nM。PD-1/PD-L1-IN-9 盐酸盐可以增强免疫细胞对肿瘤细胞的杀伤活性。PD-1/PD-L1-IN-9 盐酸盐在 CT26 小鼠模型中表现出显着的体内抗肿瘤活性。 | ||||
| GC67765 | p53 Activator 5 | 2636840-37-2 | - | |
p53 Activator 5 (compound 134A) 是一种有效的 p53 激活剂,SC150 值 <0.05 mM。p53 Activator 5 可以结合突变体 p53 并恢复 p53 突变体结合 DNA 的能力。p53 Activator 5 具有抗肿瘤活性。 | ||||
| GC67792 | NSC49652 | 908563-68-8 | - | |
NSC49652 是一种可逆的、具有口服活性的 p75 neurotrophin receptor (p75NTR,也被称为 NGFR、TNFRSF16 和 CD271) 抑制剂。 NSC49652 作用于 p75NTR 的跨膜结构域。 NSC49652 诱导凋亡(Apoptosis),影响黑色素瘤细胞活力。 | ||||
| GC67936 | Lupiwighteone | 104691-86-3 | >98.00% | |
Lupiwighteone 是一种广泛存在于野生植物中的异黄酮,具有抗氧化、抗菌和抗癌作用。Lupiwighteone 通过抑制 PI3K/Akt/mTOR 通路,诱导人乳腺癌细胞 caspase 依赖性和非依赖性凋亡 (Apoptosis)。 | ||||
| GC67966 | Methylstat | 1310877-95-2 | - | |
Methylstat 是一种有效的组蛋白去甲基化酶 (histone demethylases) 抑制剂。Methylstat 具有抗增殖活性,低细胞毒性。Methylstat 诱导细胞凋亡 (Apoptosis) 和细胞周期停滞在 G0/G1 期。Methylstat 增加 p53 和 p21 蛋白水平的表达。Methylstat 抑制由各种细胞因子诱导的血管生成。Methylstat 可用作化学探针以解决其在血管生成中的作用。 | ||||
| GC67969 | RIP1/RIP3/MLKL activator 1 | 2682850-41-3 | - | |
RIP1/RIP3/MLKL activator 1 (Compound 6i) 是一种有效的抗胶质瘤 (anti-glioma) 药物。RIP1/RIP3/MLKL activator 1 通过激活 RIP1/RIP3/MLKL 通路诱导细胞坏死 (Necroptosis)。 RIP1/RIP3/MLKL activator 1 可透过血脑屏障。 | ||||
| GC68012 | BCL6-IN-7 | 2097518-46-0 | - | |
BCL6-IN-7 是一种有效的 BCL6-corepressor 相互作用抑制剂。 | ||||
| GC68019 | NPB | 2247491-97-8 | >98.00% | |
NPB 是一种特异且有效的抑制 BAD Ser99 磷酸化的抑制剂, IC50 值为 0.41 μM。 | ||||
| GC68043 | 2-tert-Butyl-1,4-benzoquinone | 3602-55-9 | >97.00% | |
2-tert-Butyl-1,4-benzoquinone 是 butylated hydroxyanisole 的亲电代谢产物,是 2-tert-butylhydroquinone 的氧化产物。 | ||||
| GC68051 | Citric acid-d4 | 147664-83-3 | - | |
Citric acid-d4 是 Citric acid 的氘代物。Citric acid 是柑橘类水果中发现的弱有机三羧酸。柠檬酸是天然防腐剂和食品添加剂。 | ||||
| GC68213 | MitoBloCK-6 | 303215-67-0 | - | |
MitoBloCK-6 是一种有效的 Erv1/ALR 抑制剂,IC50 分别为 900 nM 和 700 nM。MitoBloCK-6 还抑制 Erv2 (IC50=1.4 μM)。MitoBloCK-6 可通过细胞色素 c 的释放诱导 hESCs 细胞凋亡。 | ||||
| GC68231 | 4-Methylsalicylic acid | 50-85-1 | >99.00% | |
4-Methylsalicylic acid 是一种水杨酸。其衍生物是一种选择性的组织-非特异性碱性磷酸酶 (TNAP) 和肠道碱性磷酸酶 (IAP) 抑制剂。 | ||||
| GC68288 | Brentuximab | 2088770-90-3 | - | |
Brentuximab 是靶向 CD30 的嵌合抗体。Brentuximab 可用于新兴靶向疗法的研究。 | ||||
